{"title": "Amylyx's ALS drug finally scores FDA approval, but that's just the tip of the iceberg for ALS research, founders say", "author": "Zoey Becker", "url": "https://www.fiercepharma.com/pharma/amylyxs-als-drug-finally-scores-fda-approval-thats-just-tip-iceberg-als-research-amylyx-co", "hostname": "fiercepharma.com", "description": "After a long road filled with scrutiny and uncertainty, Amylyx's amyotrophic lateral sclerosis (ALS) drug, known as AMX0035, has finally scored FDA approval. | After a long and winding road filled with AdComms, the FDA has finally approved Amylyx's ALS drug, Relyvrio. In an interview with Fierce Pharma, the company's co-founders say there is more research to be done and more drugs to be made to meet the unmet needs of ALS patients.", "sitename": "FiercePharma", "date": "2022-09-29", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}